Controlled release of cisplatin from pH-thermal dual responsive nanogels

Biomaterials

Volumn 34, Issue 34, 2013, Pages 8726-8740

  Peng, Jinrong ^a   Qi, Tingting ^a   Liao, Jinfeng ^a   Chu, Bingyang ^a   Yang, Qian ^a   Li, Wenting ^a   Qu, Ying ^a   Luo, Feng ^a   Qian, Zhiyong ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Cisplatin; Controlled release; Dual responsive; H+ triggering; Nanogels; Side effect

Indexed keywords

CIS-PLATIN; CONTROLLED RELEASE; DUAL RESPONSIVE; H+ TRIGGERING; NANOGELS; SIDE EFFECT;

CELLS; CYTOLOGY; DISEASES; PLATINUM COMPOUNDS;

NANOSTRUCTURED MATERIALS;

CARBOXYL GROUP; CISPLATIN; NANOGEL; NANOPARTICLE; PROTON; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER CELL; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED DRUG RELEASE; CYTOPLASM; CYTOTOXICITY; DRUG BLOOD LEVEL; DRUG CONJUGATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; INFRARED SPECTROSCOPY; LUNG CANCER; MALE; MOUSE; NEPHROTOXICITY; NONHUMAN; PH; PHLEBITIS; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; X RAY PHOTOELECTRON SPECTROSCOPY;

MUS;

CISPLATIN; CONTROLLED RELEASE; DUAL RESPONSIVE; H(+) TRIGGERING; NANOGELS; SIDE EFFECT;

ANIMALS; ANTINEOPLASTIC AGENTS; CISPLATIN; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; HELA CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; INHIBITORY CONCENTRATION 50; MALE; MCF-7 CELLS; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; RATS; RATS, SPRAGUE-DAWLEY; TEMPERATURE;

EID: 84882918550     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.07.092     Document Type: Article

References (49)

1. Long D.F., Repta A.J. Cisplatin: chemistry, distribution and biotransformation. Biopharm Drug Dispos 1981, 2:1-16.
2. Cisplatin: chemistry and biochemistry of a leading anticancer drug 1999, Verlag Helvetica Chimica Acta Zürich. Wiley-VCH. B. Lippert (Ed.).
3. Reedijk J. Why does cisplatin reach guanine-N7 with competing S-donor ligands available in the cell?. Chem Rev 1999, 99:2499-2510.
4. Wang C., Wang Y., Wang Y., Fan M., Luo F., Qian Z.Y. Characterization, pharmacokinetics and disposition of novel nanoscale preparations of paclitaxel. Int J Pharm 2011, 414:251-259.
5. Mikhail A.S., Allen C. Poly(ethylene glycol)-b-poly(ε-caprolactone) micelles containing chemically conjugated and physically entrapped docetaxel: synthesis, characterization, and the influence of the drug on micelle morphology. Biomacromolecules 2010, 11:1273-1280.
6. Zheng X., Kan B., Gou M., Fu S., Zhang J., Men K., et al. Preparation of mPEG-PLA nanoparticles for honokiol delivery invitro. Int J Pharm 2010, 386:262-267.
7. Gong C., Wei X., Wang X., Wang Y., Guo G., Mao Y., et al. Biodegradable self-assembled PEG-PCL-PEG micelles for hydrophobic honokiol delivery, part 1: preparation and characterization. Nanotechnology 2010, 21:215.
8. Ohya Y., Oue H., Nagatomi K., Ouchi T. Design of macromolecular prodrug of cisplatin using dextran with branched galactose units as targeting moieties to hepatoma cells. Biomacromolecules 2001, 2:927-933.
9. Lee S.M., Chen H., Dettmer C.M., O'Halloran T.V., Nguyen S.T. Polymer-caged lipsomes: a pH-responsive delivery system with high stability. JAm Chem Soc 2007, 129:15096-15097.
10. Ashley C.E., Carnes E.C., Phillips G.K., Padilla D., Durfee P.N., Brown P.A., et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers. Nat Mater 2011, 10:389-397.
11. Dhar S., Liu Z., Thomale J., Dai H., Lippard S.J. Targeted single-wall carbon nanotube-mediated Pt(IV) prodrug delivery using folate as a homing device. JAm Chem Soc 2008, 130:11467-11476.
12. Lee S.M., O'Halloran T.V., Nguyen S.T. Polymer-caged nanobins for synergistic cisplatin doxorubicin combination chemotherapy. JAm Chem Soc 2010, 132:17130-17138.
13. Huynh V.T., Quek J.Y., de Souza P.L., Stenzel M.H. Block copolymer micelles with pendant bifunctional chelator for platinum drugs: effect of spacer length on the viability of tumor cells. Biomacromolecules 2012, 13:1010-1023.
14. Huynh V.T., Binauld S., de Souza P.L., Stenzel M.H. Acid degradable cross-linked micelles for the delivery of cisplatin: a comparison with nondegradable cross-linker. Chem Mater 2012, 24:3197-3211.
15. Huynh V.T., de Souza P., Stenzel M.H. Polymeric micelles with pendant dicarboxylato chelating ligands prepared via a michael addition for cis-platinum drug delivery. Macromolecules 2011, 44:7888-7900.
16. Peng X.H., Wang Y., Huang D., Wang Y., Shin H.J., Chen Z., et al. Targeted delivery of cisplatin to lung cancer using ScFvEGFR-heparin-cisplatin nanoparticles. ACS Nano 2011, 5:9480-9493.
17. Huang C., Neoh K.G., Xu L., Kang E.T., Chiong E. Polymeric nanoparticles with encapsulated superparamagnetic iron oxide and conjugated cisplatin for potential bladder cancer therapy. Biomacromolecules 2012, 13:2513-2520.
18. Kabanov A.V., Vinogradov S.V. Nanogels as pharmaceutical carriers: finite networks of infinite capabilities. Angew Chem Int Ed 2009, 48:5418-5429.
19. Nunes S.P., Behzad A.R., Hooghan B., Sougrat R., Karunakaran M., Pradeep N., et al. Switchable pH-responsive polymeric membranes prepared via block copolymer micelle assembly. ACS Nano 2011, 5:3516-3522.
20. Shen X., Zhang L., Jiang X., Hu Y., Guo J. Reversible surface switching of nanogel triggered by external stimuli. Angew Chem Int Ed 2007, 46:7104-7107.
21. Du J., Sun T., Song W., Wu J., Wang J. Atumor-acidity-activated charge-conversional nanogel as an intelligent vehicle for promoted tumoral-cell uptake and drug delivery. Angew Chem Int Ed 2010, 49:3621-3626.
22. López-Pérez P.M., da Silva R.M.P., Pashkuleva I., Román J.S., Reis R.L. Temperature as a single on-off parameter controlling nanoparticles growing, stabilization and fast disentanglement. Adv Mater 2010, 22:4288-4292.
23. Huang X., Misra G.P., Vaish A., Flanagan J.M., Sutermaster B., Lowe T.L. Novel nanogels with both thermoresponsive and hydrolytically degradable properties. Macromolecules 2008, 41:8339-8345.
24. Lee H., Mok H., Lee S., Oh Y.K., Park T.G. Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. JControl Release 2007, 119:245-252.
25. Steinhilber D., Sisson A.L., Mangoldt D., Welker P., Licha K., Haag R. Synthesis, reductive cleavage, and cellular interaction studies of biodegradable, polyglycerol nanogels. Adv Funct Mater 2010, 20:4133-4138.
26. Li Y., Zhu L., Liu Z., Cheng R., Meng F., Cui J., et al. Reversibly stabilized multifunctional dextran nanoparticles efficiently deliver doxorubicin into the nuclei of cancer cells. Angew Chem Int Ed 2009, 48:9914-9918.
27. Kang H., Trondoli A.C., Zhu G., Chen Y., Chang Y., Liu H., et al. Near-infrared light-responsive coreshell nanogels for targeted drug delivery. ACS Nano 2011, 5:5094-5099.
28. Berger S., Ornatsky O., Baranov V., Winnik M.A., Pich A. Hybrid nanogels by encapsulation of lanthanide-doped LaF3 nanoparticles as elemental tags for detection by atomic mass spectrometry. JMater Chem 2010, 20:5141-5150.
29. Gorelikov I., Field L.M., Kumacheva E. Hybrid microgels photoresponsive in the near-infrared spectral range. JAm Chem Soc 2004, 126:15938-15939.
30. Takahashi H., Sawada S., Akiyoshi K. Amphiphilic polysaccharide nanoballs: a new building block for nanogel biomedical engineering and artificial chaperones. ACS Nano 2011, 5:337-345.
31. Wu W., Shen J., Banerjee P., Zhou S. Amultifuntional nanoplatform based on responsive fluorescent plasmonic ZnO-Au@PEG hybrid nanogels. Adv Funct Mater 2011, 21:2830-2839.
32. Riedinger A., Leal M.P., Deka S.R., George C., Franchini I.R., Falqui A., et al. "Nanohybrids" based on pH-responsive hydrogels and inorganic nanoparticles for drug delivery and sensor applications. Nano Lett 2011, 11:3136-3141.
33. Oh J.K., Lee D.I., Park J.M. Biopolymer-based microgels/nanogels for drug delivery applications. Prog Polym Sci 2009, 34:1261-1282.
34. Peng J.R., Qi T., Liao J., Fan M., Luo F., Qian Z.Y., et al. Synthesis and characterization of novel dual-responsive nanogels and their application as drug delivery systems. Nanoscale 2012, 4:2694-2704.
35. 4 nanoparticles for target-specific platin delivery. JAm Chem Soc 2009, 131:4216-4217.
36. Ding D., Zhu Z., Li R., Li X., Wu W., Jiang X., et al. Nanospheres-incorporated implantable hydrogel as a trans-tissue drug delivery system. ACS Nano 2011, 5:2520-2534.
37. Tauro J.R., Gemeinhart R.A. Matrix metalloprotease triggered delivery of cancerchemotherapeutics from hydrogel matrixes. Bioconjug Chem 2005, 16:1133-1139.
38. Tauro J.R., Gemeinhart R.A. Extracellular protease activation of chemotherapeutics from hydrogel matrices: a new paradigm for local chemotherapy. Mol Pharm 2005, 2:435-438.
39. Ding D., Wang J., Zhu Z., Li R., Wu W., Liu B., et al. Tumor accumulation, penetration, and antitumor response of cisplatin-loaded gelatin/poly(acrylic acid) nanoparticles. ACS Appl Mater Inter 2012, 4:1838-1846.
40. Lu Y., Ballauff M. Thermosensitive core-shell microgels: from colloidal model systems to nanoreactors. Prog Polym Sci 2011, 36:767-792.
41. Ghugare S.V., Chiessi E., Fink R., Gerelli Y., Scotti A., Deriu A., et al. Structural investigation on thermoresponsive PVA/poly(methacrylate-co-N-isopropylacrylamide) microgels across the volume phase transition. Macromolecules 2011, 44:4470-4478.
42. Hu X., Tong Z., Lyon L.A. Control of poly(N-isopropylacrylamide) microgel network structure by precipitation polymerization near the lower critical solution temperature. Langmuir 2011, 27:4142-4148.
43. Zhao Y., Zheng C., Wang Q., Fang J., Zhou G., Zhao H., et al. Permanent and peripheral embolization: temperature-sensitive p(N-isopropylacrylamide-co-butyl methylacrylate) nanogel as a novel blood-vessel-embolic material in the interventional therapy of liver tumors. Adv Funct Mater 2011, 21:2035-2042.
44. Hoare T., Timko B.P., Santamaria J., Goya G.F., Irusta S., Lau S., et al. Magnetically triggered nanocomposite membranes: a versatile platform for triggered drug release. Nano Lett 2011, 11:1395-1400.
45. Yavuz M.S., Cheng Y., Chen J., Cobley C.M., Zhang Q., Rycenga M., et al. Gold nanocages covered by smart polymers for controlled release with near-infrared light. Nat Mater 2009, 8:935-939.
46. Nukolova N.V., Oberoi H.S., Cohen S.M., Kabanov A.V., Bronich T.K. Folate-decorated nanogels for targeted therapy of ovarian cancer. Biomaterials 2011, 32:5417-5426.
47. Venditto VJ, Simanek EE. Cancer therapies utilizing the camptothecins: a review of the invivo literature. Mol Pharmaceut 7;307-49.
48. Gao J., Liu Y., Zingaro R.A. Cytotoxic activities, cellular uptake, gene regulation, and optical imaging of novel platinum(II) complexes. Chem Res Toxicol 2009, 22:1705-1712.
49. Sar D.G., Montes-Bayon M., Gonzalez E.B., Zapico L.M.S., Sanz-Medel A. Reduction of cisplatin-induced nephrotoxicity invivo by selenomethionine: the effect on cisplatin DNA adducts. Chem Res Toxicol 2011, 24:896-904.